Education And Debate Medical journals and pharmaceutical companies: uneasy bedfellows BMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7400.1202 (Published 29 May 2003) Cite this as: BMJ 2003;326:1202 Article Related content Metrics Responses Peer review Related articles Review In praise of the “devil” Published: 29 May 2003; BMJ 326 doi:10.1136/bmj.326.7400.1220 Analysis And Comment Commercial influence and the content of medical journals Published: 15 June 2006; BMJ 332 doi:10.1136/bmj.332.7555.1444 Head To Head Should journals sell reprints? Yes Published: 14 October 2011; BMJ 343 doi:10.1136/bmj.d6428 See more Constitutional symptoms in a young person BMJ December 07, 2016, 355 i5781; DOI: https://doi.org/10.1136/bmj.i5781 What it feels like to be an interesting teaching opportunity BMJ December 07, 2016, 355 i6190; DOI: https://doi.org/10.1136/bmj.i6190 Author’s reply to Dangoor and colleagues BMJ December 05, 2016, 355 i6508; DOI: https://doi.org/10.1136/bmj.i6508 Time for guidelines on safety netting? BMJ December 05, 2016, 355 i6411; DOI: https://doi.org/10.1136/bmj.i6411 The BMJ Christmas appeal 2016-7: Orbis, the sight savers BMJ December 01, 2016, 355 i6425; DOI: https://doi.org/10.1136/bmj.i6425 Cited by... Open access policies of leading medical journals: a cross-sectional studyAbstract Fulltext PDF Open access policies of leading medical journals: a cross-sectional studyAbstract Fulltext PDF The Fate of Manuscripts Rejected by The Journal of Bone and Joint Surgery (American Volume)Abstract Fulltext PDF Should journals sell reprints? YesAbstract Fulltext PDF An open challenge: Open access and the challenges for scientific publishingAbstract Fulltext PDF Commercial influence and the content of medical journalsAbstract Fulltext PDF Lessons from the withdrawal of rofecoxibAbstract Fulltext PDF Continuing Medical Education in Diabetes: The Impending CrisisAbstract Fulltext PDF Role of entacapone in later Parkinson's disease not yet establishedAbstract Fulltext PDF Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: EntanglementAbstract Fulltext PDF No more free lunchesAbstract Fulltext PDF